Nephros Stock Forward View
| NEPH Stock | USD 3.89 0.13 3.23% |
Nephros Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Nephros' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 11th of February 2026 the relative strength index (rsi) of Nephros' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 0.729 | EPS Estimate Next Quarter (0.01) | EPS Estimate Current Year 0.11 | EPS Estimate Next Year 0.15 | Wall Street Target Price 7 |
Using Nephros hype-based prediction, you can estimate the value of Nephros from the perspective of Nephros response to recently generated media hype and the effects of current headlines on its competitors.
Nephros Relative Strength Index
The Naive Prediction forecasted value of Nephros on the next trading day is expected to be 3.76 with a mean absolute deviation of 0.18 and the sum of the absolute errors of 11.31.Nephros Hype to Price Pattern
Investor biases related to Nephros' public news can be used to forecast risks associated with an investment in Nephros. The trend in average sentiment can be used to explain how an investor holding Nephros can time the market purely based on public headlines and social activities around Nephros. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Nephros' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Nephros.
The Naive Prediction forecasted value of Nephros on the next trading day is expected to be 3.76 with a mean absolute deviation of 0.18 and the sum of the absolute errors of 11.31. Nephros after-hype prediction price | USD 4.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Nephros to cross-verify your projections. Nephros Additional Predictive Modules
Most predictive techniques to examine Nephros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nephros using various technical indicators. When you analyze Nephros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Nephros Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Nephros' financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2004-06-30 | Previous Quarter 5.1 M | Current Value 5.2 M | Quarterly Volatility 2.4 M |
Nephros Naive Prediction Price Forecast For the 12th of February 2026
Given 90 days horizon, the Naive Prediction forecasted value of Nephros on the next trading day is expected to be 3.76 with a mean absolute deviation of 0.18, mean absolute percentage error of 0.06, and the sum of the absolute errors of 11.31.Please note that although there have been many attempts to predict Nephros Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nephros' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Nephros Stock Forecast Pattern
| Backtest Nephros | Nephros Price Prediction | Research Analysis |
Nephros Forecasted Value
In the context of forecasting Nephros' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nephros' downside and upside margins for the forecasting period are 0.04 and 9.89, respectively. We have considered Nephros' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Nephros stock data series using in forecasting. Note that when a statistical model is used to represent Nephros stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.0699 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1825 |
| MAPE | Mean absolute percentage error | 0.0372 |
| SAE | Sum of the absolute errors | 11.3121 |
Predictive Modules for Nephros
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nephros. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nephros After-Hype Price Density Analysis
As far as predicting the price of Nephros at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nephros or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nephros, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nephros Estimiated After-Hype Price Volatility
In the context of predicting Nephros' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nephros' historical news coverage. Nephros' after-hype downside and upside margins for the prediction period are 0.20 and 10.22, respectively. We have considered Nephros' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nephros is risky at this time. Analysis and calculation of next after-hype price of Nephros is based on 3 months time horizon.
Nephros Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Nephros is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nephros backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nephros, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 6.13 | 0.20 | 0.02 | 17 Events / Month | 5 Events / Month | In about 17 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.89 | 4.09 | 5.14 |
|
Nephros Hype Timeline
Nephros is now traded for 3.89. The entity has historical hype elasticity of 0.2, and average elasticity to hype of competition of 0.02. Nephros is projected to increase in value after the next headline, with the price projected to jump to 4.09 or above. The average volatility of media hype impact on the company the price is about 119.96%. The price growth on the next news is projected to be 5.14%, whereas the daily expected return is now at -0.04%. The volatility of related hype on Nephros is about 1230.92%, with the expected price after the next announcement by competition of 3.91. Nephros currently holds about 4.18 M in cash with (492 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. Given the investment horizon of 90 days the next projected press release will be in about 17 days. Check out Historical Fundamental Analysis of Nephros to cross-verify your projections.Nephros Related Hype Analysis
Having access to credible news sources related to Nephros' direct competition is more important than ever and may enhance your ability to predict Nephros' future price movements. Getting to know how Nephros' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nephros may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DXR | Daxor | 0.16 | 10 per month | 0.00 | (0.07) | 4.20 | (4.74) | 14.79 | |
| BEAT | Heartbeam | 0.10 | 10 per month | 10.28 | 0.04 | 28.33 | (11.73) | 103.08 | |
| ONMD | OneMedNet Corp | 0.05 | 6 per month | 0.00 | (0.12) | 13.71 | (16.00) | 53.01 | |
| ICCC | ImmuCell | (0.29) | 9 per month | 3.61 | 0.01 | 5.49 | (5.18) | 13.87 | |
| OSTX | OS Therapies Incorporated | (0.03) | 9 per month | 0.00 | (0.14) | 5.56 | (5.81) | 16.39 | |
| ZJYL | JIN MEDICAL INTERNATIONAL | 0.02 | 10 per month | 0.00 | (0.12) | 7.69 | (9.52) | 39.69 | |
| OTLK | OUTLOOK THERAPEUTICS INC | 0.02 | 11 per month | 0.00 | (0.11) | 11.32 | (11.11) | 73.07 | |
| NRXP | NRX Pharmaceuticals | (0.13) | 9 per month | 0.00 | (0.09) | 8.06 | (8.24) | 21.29 | |
| SPRB | Spruce Biosciences Common | 5.11 | 5 per month | 0.00 | (0.07) | 9.21 | (9.96) | 27.07 | |
| HOWL | Werewolf Therapeutics | (0.03) | 8 per month | 0.00 | (0.08) | 8.70 | (8.00) | 51.90 |
Other Forecasting Options for Nephros
For every potential investor in Nephros, whether a beginner or expert, Nephros' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nephros Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nephros. Basic forecasting techniques help filter out the noise by identifying Nephros' price trends.Nephros Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nephros stock to make a market-neutral strategy. Peer analysis of Nephros could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Nephros Market Strength Events
Market strength indicators help investors to evaluate how Nephros stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nephros shares will generate the highest return on investment. By undertsting and applying Nephros stock market strength indicators, traders can identify Nephros entry and exit signals to maximize returns.
| Accumulation Distribution | 3596.51 | |||
| Daily Balance Of Power | (0.50) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 3.87 | |||
| Day Typical Price | 3.88 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.13) |
Nephros Risk Indicators
The analysis of Nephros' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nephros' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nephros stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.39 | |||
| Standard Deviation | 6.2 | |||
| Variance | 38.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Nephros
The number of cover stories for Nephros depends on current market conditions and Nephros' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nephros is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nephros' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Nephros Short Properties
Nephros' future price predictability will typically decrease when Nephros' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nephros often depends not only on the future outlook of the potential Nephros' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nephros' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.6 M | |
| Cash And Short Term Investments | 3.8 M |
Check out Historical Fundamental Analysis of Nephros to cross-verify your projections. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is there potential for Household Appliances market expansion? Will Nephros introduce new products? Factors like these will boost the valuation of Nephros. Anticipated expansion of Nephros directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.729 | Earnings Share 0.14 | Revenue Per Share | Quarterly Revenue Growth 0.354 | Return On Assets |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nephros' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nephros should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nephros' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.